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346a Tuesday , March 8, 2011placed in different locations throughout the protein, including the very C-
terminus. Addition of a charged, cleavable signal peptide to the N-terminus
of the protein indicates that topology does not change after insertion into
the membrane. These observation point to an unanticipated plasticity in
pre-insertion membrane protein topology.1876-Plat
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There are two questions we would like to address: 1) what is the molecular
mechanism of a polypeptide insertion into a lipid bilayer and formation of
transmembrane helix? 2) Are there any transient changes of a lipid bilayer
in process of a polypeptide insertion and folding? As a convenient system
we are studying pHLIP (pH (Low) Insertion Peptide) insertion into a mem-
brane and folding, which is modulated by pH. Previously we showed, that
insertion of pHLIP occurs in several steps, with rapid (0.1 sec) interfacial
helix formation followed by a much slower (100 sec) insertion pathway to
form a transmembrane helix. The reverse process of unfolding and peptide
exit from the bilayer core, which can be induced by a rapid pH jump from
acidic to basic, proceeds much faster than folding/insertion and through dif-
ferent intermediate states. We designed two truncated pHLIP-variants by re-
moving Asp and Glu residues from the C-terminus, which goes across
a membrane. Our kinetic studies indicate that truncated versions of pHLIP
insert across a membrane much faster than original (WT) sequence and
with less number of intermediate states. Thus, the rate of insertion directly
depends on probability of protonation of C-terminal Asp and Glu residues,
and translocation of the C-terminus across a bilayer. To understand what
are the structural intermediates along the folding pathway, we designed
three single-tryptophan pHLIP-variants, where a Trp residue is positioned
at the beginning, middle and end of the transmembrane part of the peptide.
To study changes, which might occur with a lipid bilayer in a process of
peptide insertion and folding, we employed SAXS (small-angle x-ray
scattering) technique. A new kinetic model of pHLIP insertion/exit will
be discussed.1877-Plat
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Influenza viruses A and B contain M2 proton channels (A/M2 and BM2
respectively) that are vital for viral replication. Despite performing similar
roles, A/M2 and BM2 have little sequence similarity, apart from a common
HxxxW motif thought to be responsible for the pH-dependent channel gat-
ing. The A/M2 TM domain has been extensively studied, both experimen-
tally and computationally. It is structurally well-characterized with several
structures of the TM domain deposited in the Protein Data Bank. The struc-
tures were solved under various conditions using a range of techniques and
show that the A/M2 channel exists in multiple conformations. The only
structure of BM2 available is the recently-determined solution NMR struc-
ture of the full length BM2 protein (PDB id 2KIX); the first full length
proton channel structure to be determined. It is structurally of interest as
it was shown to form a coiled-coil tetramer. We have performed a series
of atomistic Molecular Dynamics simulations of the BM2 TM domain (res-
idues 1-33) under a range of conditions. The structure and dynamics of the
channel are compared in a lipid bilayer environment and in detergent mi-
celles (including 1,2-dihexanoyl phosphocholine, the detergent used in the
solution NMR study). These studies allow us to identify key lipid-/deter-
gent-protein interactions and compare the structural plasticity of BM2 to
that of A/M2. A further aspect of these simulations is the unbiased forma-
tion of membrane protein-detergent complexes (PDCs). Membrane proteins
are generally studied in detergent environments. However, relatively little is
known about these PDCs. These simulations provide further informationabout the distribution, interactions and dynamics of detergent molecules
within the PDC.
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Palmitoylation has recently been shown to stabilize m-opioid receptor
(MOR) homodimerization and receptor-G protein coupling. The MOR pal-
mitoylation site is located at the intracellular end of transmembrane helix 3
(TMH3) (C3.55(170)) rather than in the C-terminus. In work reported here,
we tested the hypothesis that a specific cholesterol interaction with palmi-
toylated C3.55(170) may enhance interactions at the MOR homodimer in-
terface. First, interactive docking studies were used to orient two MOR/
cholesterol protomers at the symmetric TMH4-TMH5 interface of mouse
dark state rhodopsin. Following energy minimization of the complex, the
MOR protomers were found to form an interface that involves N4.41,
I4.44, C4.48, I4.51, A4.55 and P4.59, with the cholesterol from protomer
A interacting with residues on protomer B and vice versa. Cholesterol
was found to contribute 24.7% to the total interaction energy at the dimer
interface. In order to explore the structure and dynamics of this unique cho-
lesterol binding site, two sets of NAMD molecular dynamics simulations
were then performed employing the CHARMM 27 all atom force field.
In the first set of simulations in a fully hydrated POPC bilayer, we exam-
ined the structure and stability of a cholesterol docked between palmitoy-
lated C3.55(170) and the MOR monomer. The structure, location and
motion of this cholesterol was monitored. In a second set of simulations,
the uniqueness of this binding site was tested with the MOR monomer
model embedded in a fully hydrated 30% cholesterol/POPC lipid bilayer.
Here the cholesterol molecules were randomly placed in the simulation
cell. In particular these simulations address the specificity (location/dura-
tion) of alternate cholesterol-mu opioid contact sites. Our initial results
suggest that the docked binding site at palmitoylated C3.55(170) is a loca-
tion for specific binding of cholesterol at MOR. [Support: KO5 DA021358
(PHR) and RO1 DA023905 (PYL)]
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Mutations in the dysferlin gene cause progressive muscle weakness and
muscle wasting. Previously dysferlin was found to play a key role in
the Ca2þ-activated membrane repair process of striated myocytes. How-
ever, it remains to be explored as to how dysferlin is involved in muscle
membrane repair. Here we report for the first time that dysferlin forms
a homodimer in living cells as well as in detergent-solubilized cell lysates.
Sucrose gradient fractionation experiments showed that endogenous dysfer-
lin from digitonin-solubilized skeletal muscle membranes migrated into
heavy fractions. A self-associated fluorescent protein labeled dysferlin
(ECFP-dysferlin and EYFP-dysferlin) complex in living AAV293 cells
and adult skeletal muscle fibers was demonstrated by fluorescence reso-
nance energy transfer (FRET) assay. Importantly, fluorescent protein tag
at the N terminus of dysferlin did not impair the function of dysferlin
in restoring the membrane repair efficiency in dysferlin-deficient skeletal
muscle fibers. FRET between ECFP-dysferlin and EYFP-dysferlin in skel-
etal muscle fibers showed hyperbolic dependence on protein concentration,
with a maximum efficiency of 35.3% and a very low KD. The observed
FRET corresponds to a probe separation distance of 54.4 A˚, according
to a computational model of dimeric FRET. Dysferlin dimerization was
further confirmed by using fluorescence fluctuation spectroscopy with pho-
ton counting histogram analyses. Moreover, myoferlin, a mammalian or-
thologue of dysferlin, also forms dimer. The heterodimeric affinity
between dysferlin and myoferlin is weaker than that of either homodimer.
Finally, the transmembrane domain was identified to mediate the dimeriza-
tion of dysferlin. Therefore, our data demonstrate that dysferlin forms a ho-
modimer in cells, which may be a common feature for ferlin-1-like protein
family.
